Skip to content

Solid Biosciences Inc. SLDB Return on invested capital

Return on invested capital at other companies

Biogen logo
BiogenBIIB
7.8%-0.4pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
17.5%+5.1pp
Insmed logo
InsmedINSM
-149.4%-29.5pp
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-188.2%+14.8pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-6,605%
uniQure logo
uniQureQURE
-119%+424pp

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$910.66M+145%
Enterprise value$634.23M+244%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

Based on trailing twelve months.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s return on invested capital?
Solid Biosciences Inc. (SLDB) reported return on invested capital of -191.5% in Q1 2026.
How has Solid Biosciences Inc.'s return on invested capital changed year-over-year?
Solid Biosciences Inc.'s return on invested capital decreased by 51.7% year-over-year, from -126.2% to -191.5%.
What is the long-term trend for Solid Biosciences Inc.'s return on invested capital?
Over 3 years (2022 to 2025), Solid Biosciences Inc.'s return on invested capital has grown at a 10.1% compound annual growth rate (CAGR), from -120.8% to -161.1%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.